White matter edematous change with moderate vascular lesions in pretreated acute stage of leukoencephalopathy with cerebral amyloid angiopathy
暂无分享,去创建一个
K. Moriyoshi | T. Ayaki | T. Maki | Ryosuke Takahashi | Michikazu Nakamura | M. Sainouchi | Y. Kuwata | K. Yasuda | Fangzhou Li
[1] A. Fagan,et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline , 2020, Nature.
[2] S. Tetsuka,et al. Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics , 2019, Journal of the Neurological Sciences.
[3] C. Greene,et al. Claudin-5: gatekeeper of neurological function , 2019, Fluids and Barriers of the CNS.
[4] H. Markus,et al. Encephalopathy in a Large Cohort of British Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Patients , 2019, Stroke.
[5] B. Kleinschmidt-DeMasters,et al. PRES: Review of Histological Features , 2018, Journal of neuropathology and experimental neurology.
[6] Paul Edison,et al. Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease , 2017, Brain : a journal of neurology.
[7] D. Tang‐Wai,et al. Clinical Reasoning: A case of subacute cognitive decline in a 76-year-old man , 2016, Neurology.
[8] M. Frosch,et al. Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation. , 2016, JAMA neurology.
[9] J. Mangin,et al. White Matter Edema at the Early Stage of Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy , 2015, Stroke.
[10] A. Kakita,et al. Cerebral amyloid angiopathy‐related leukoencephalopathy: Successful steroid treatment for neurological deficits and subcortical white matter lesions partly involving the cortical gray matter , 2014 .
[11] K. Jellinger,et al. Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. , 2014, American journal of neurodegenerative disease.
[12] À. Rovira,et al. Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome , 2014, Neuroradiology.
[13] Jonathan M. Morris,et al. Aβ-related angiitis , 2013, Neurology.
[14] Mahlon D. Johnson,et al. Deficiency in Mural Vascular Cells Coincides with Blood–Brain Barrier Disruption in Alzheimer's Disease , 2013, Brain pathology.
[15] M. Heneka,et al. NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.
[16] Hitoshi Takahashi,et al. Multiple cerebral infarcts with a few vasculitic lesions in the chronic stage of cerebral amyloid angiopathy‐related inflammation , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.
[17] G. Hunder,et al. Adult primary central nervous system vasculitis , 2012, The Lancet.
[18] Clifford R. Jack,et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup , 2011, Alzheimer's & Dementia.
[19] B. Synek,et al. Cerebral amyloid angiopathy related inflammation: three case reports and a review , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[20] Berislav V. Zlokovic,et al. Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.
[21] G. Hunder,et al. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy. , 2008, Rheumatology.
[22] S. Love,et al. Aβ-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy , 2005 .
[23] J. Krakauer,et al. Reversible leukoencephalopathy associated with cerebral amyloid angiopathy , 2004, Neurology.
[24] H. Braak,et al. Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .
[25] L R Caplan,et al. A reversible posterior leukoencephalopathy syndrome. , 1996, The New England journal of medicine.
[26] A. Alavi,et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.